Patent · US Active

Cardiopathy-reducing phosphodiester lipids

US10975111B2 · kind B2 · utility

2Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2019
Grant dateApr 13, 2021
Priority date—
Expiry dateJun 26, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes compound having the following structural formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.